Causes And Pathogenesis Of AIDS In
Organ Transplant And/Or Blood Transfusion Patients
From 'HIV Does Not Cause Aids' by Mohammed Ali Al-Bayati, (May 2002)

As of January 1, 1997, the number of patients who received blood transfusions, blood components or tissues then subsequently developed AIDS in USA is 7,888 (Al-Bayati, 1999). The list of adverse reactions to blood transfusion is present and the standard treatment used to prevent or cure these reactions is glucocorticoid as stated by Fauci et., (1998). For example, the risk of getting an allergic reaction from a blood transfusion is 1-4 per 100. The risk for delayed hemolytic reaction is 1 per 1,500. In contrast, the risk of infection with HIV from blood transfusion is 1 per 490,000 (Fauci, et. al., 1998). However, immune suppression as a result of the use of glucocorticoids in these patients was not investigated. Furthermore, glucocorticoids and other immunosuppressive agents are also used to prevent tissue rejection in organ transplant patients. The complications from these treatment and the list of opportunistic diseases are also described by Fauci et al., (1998). The list of opportunistic diseases in organ transplant patient receiving immunosuppressive agents are identical to the list of opportunistic diseases listed in Fauci et al., (1998) in people with AIDS.